Tier 3 · Filer Universe

FATE THERAPEUTICS INC

FATE · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.

Price
$2.36
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0001434316
Liquidity rank
#3409
Observed dollar volume

Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.

SEC XBRL facts

FieldValuePeriod endFiling
Annual revenue$6.65M2025-12-310001193125-26-073699
Annual diluted EPS-1.152025-12-310001193125-26-073699
Quarterly revenue$1.3M2026-03-310001193125-26-220696
Quarterly diluted EPS-0.262026-03-310001193125-26-220696

SEC EDGAR Frames batch generated 2026-07-30T09:48:51.912Z. Frames are calendar-aligned and may not cover every filer or fiscal period.

Filings and machine access

Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract

Context paths

HealthcareNasdaqBMY · Tier 1 peerPFE · Tier 1 peerISRG · Tier 1 peerMRK · Tier 1 peer

Provenance